A Comprehensive Review of Analytical Methods for the Determination of Riluzole and Fluvoxamine Maleate in Pharmaceutical Dosage Forms
Riluzole and Fluvoxamine Maleate are therapeutically important drugs widely used in the management of neurological and psychiatric disorders, respectively. Riluzole is a benzothiazole derivative approved for the treatment of Amyotrophic Lateral Sclerosis (ALS), where it exerts neuroprotective effects by inhibiting glutamatergic neurotransmission and reducing neuronal excitotoxicity. Fluvoxamine Maleate, a selective serotonin reuptake inhibitor (SSRI), is extensively prescribed for depression, obsessive-compulsive disorder, anxiety disorders, and related psychiatric conditions. Owing to their significant clinical utility, the development of reliable analytical methods for their quantitative estimation is essential to ensure pharmaceutical quality, safety, efficacy, and regulatory compliance. The present review provides a comprehensive overview of the physicochemical properties, therapeutic significance, and reported analytical approaches for the determination of Riluzole and Fluvoxamine Maleate. Various analytical techniques reported in the literature, including Reverse Phase High-Performance Liquid Chromatography (RP-HPLC), Ultra Performance Liquid Chromatography (UPLC), High-Performance Thin Layer Chromatography (HPTLC), LC-MS/MS, and stability-indicating chromatographic methods, have been critically evaluated. These methods have demonstrated satisfactory linearity, precision, accuracy, specificity, robustness, and sensitivity for the estimation of individual drugs in bulk materials, pharmaceutical formulations, and biological matrices. The literature survey reveals that RP-HPLC remains the most preferred analytical technique owing to its simplicity, reproducibility, cost-effectiveness, and regulatory acceptance. Although numerous validated methods are available for the individual analysis of Riluzole and Fluvoxamine Maleate, studies reporting their simultaneous estimation are limited. This highlights the necessity for the development of a novel, rapid, precise, accurate, and stability-indicating RP-HPLC method for the simultaneous determination of both drugs in bulk and synthetic mixtures. Such a method would support routine quality control, formulation development, stability studies, and pharmaceutical research while improving analytical efficiency and reducing operational costs.
Authors
- Dr. Pragnesh Patani
- Urvisha Panchal
- Fenali Patel
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24389351
- Primary Topic
- Analytical Methods in Pharmaceuticals
- Type
- article
- Field-Weighted Citation Impact
- 0.00